home / stock / adma / adma news

ADMA News and Press, ADMA Biologics Inc From 05/21/19

Stock Information
Company Name: ADMA Biologics Inc
Stock Symbol: ADMA
Market: NASDAQ
Website: admabiologics.com
Menu
ADMA ADMA Quote ADMA Short ADMA News ADMA Articles ADMA Message Board
Get ADMA Alerts

News, Short Squeeze, Breakout and More Instantly...
ADMA - ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

RAMSEY, N.J. and BOCA RATON, Fla., May 21, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops spe...
ADMA - ADMA Bio down 5% on pricing equity offering

ADMA Biologics (NASDAQ: ADMA ) has priced its public offering of 11.25M common shares at $4.00 per share, for gross proceeds of ~$45M. More news on: ADMA Biologics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ADMA - WIX and FTCH among premarket losers

Virtusa (NASDAQ: VRTU )  -24%  on Q4 earnings . More news on: Virtusa Corporation, Cellectar Biosciences, Inc., EDAP TMS S.A., Stocks on the move, Read more ...

ADMA - NeuBase Therapeutics Designates Industry Leaders to Board of Directors

PITTSBURGH, May 16, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address genetic diseases, today announced that it has designated four experienced executives from the biotechnology in...
ADMA - ADMA Biologics Announces Proposed $45 Million Public Offering of Common Stock

RAMSEY, N.J. and BOCA RATON, Fla., May 15, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops spe...

ADMA - GPRO, JD among premarket gainers

Buckeye Partners, L.P. (NYSE: BPL ) +27%  on Q1 earnings . More news on: Buckeye Partners, L.P., Cool Holdings, Inc., Westport Fuel Systems Inc., Stocks on the move, Read more ...

ADMA - ADMA Bio on go to launch Bivigam in U.S. for antibody production disorder

The FDA has approved ADMA Biologics' (NASDAQ: ADMA ) Prior Approval Supplement for BIVIGAM (immune globulin intravenous (human), 10% liquid) for its optimized intravenous immune globulin manufacturing process. More news on: ADMA Biologics, Inc., Healthcare stocks news, Stocks on the move...
ADMA - FDA Approves Prior Approval Supplement for BIVIGAM®

RAMSEY, N.J. and BOCA RATON, Fla., May 10, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops sp...

ADMA - ADMA Biologics beats by $0.04, beats on revenue

ADMA Biologics (NASDAQ: ADMA ): Q1 GAAP EPS of -$0.28 beats by $0.04 . More news on: ADMA Biologics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

ADMA - ADMA Biologics Reports First Quarter 2019 Financial Results

RAMSEY, N.J. and BOCA RATON, Fla., May 08, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops sp...
Previous 10 Next 10